Minimal residual disease monitoring in acute myeloid leukaemia: are we ready to move from bone marrow to peripheral blood?-Reference-Cited by-同舟云学术

Minimal residual disease monitoring in acute myeloid leukaemia: are we ready to move from bone marrow to peripheral blood?

Published:2020-03-19 Issue:2 Volume:190 Page:135-136
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Malagola Michele¹²^ORCID,Bernardi Simona¹²³^ORCID,Polverelli Nicola¹²^ORCID,Russo Domenico¹²^ORCID

Affiliation:

1. Chair of Hematology Department of Clinical and Experimental Sciences University of Brescia Brescia Italy

2. Unit of Blood Disease and Stem Cell Transplantation ASST Spedali Civili of Brescia Brescia Italy

3. CREA Laboratory (Hematological‐Research AIL Centre) ASST‐Spedali Civili Brescia Brescia Italy

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16579

Reference17 articles.

1. Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia;Løvvik Juul‐Dam K;Br J Hematol,2020

2. Detection and management of acute myeloid leukemia measurable residual disease

3. Evaluating measurable residual disease in acute myeloid leukemia

4. Minimal Residual Disease in Acute Myeloid Leukemia

5. Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges;Frontiers in Immunology;2024-06-13

2. Digital PCR as a New Method for Minimal Residual Disease Monitoring and Treatment Free Remission Management in Chronic Myeloid Leukemia Patients: Is It Reliable?;Hemato;2022-12-30

3. Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection;Cancers;2022-09-16

4. Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia;Cancers;2022-07-26

5. Exosomes and Extracellular Vesicles in Myeloid Neoplasia: The Multiple and Complex Roles Played by These “Magic Bullets”;Biology;2021-02-02